Australia markets closed

Botanix Pharmaceuticals Limited (BOT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.05600.0000 (0.00%)
At close: 03:39PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 67.69M
Enterprise value 60.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)8.30
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.66

Trading information

Stock price history

Beta (5Y monthly) 1.99
52-week change 3-6.67%
S&P500 52-week change 3-8.00%
52-week high 30.0950
52-week low 30.0520
50-day moving average 30.0584
200-day moving average 30.0672

Share statistics

Avg vol (3-month) 3854.96k
Avg vol (10-day) 3634.13k
Shares outstanding 51.19B
Implied shares outstanding 6N/A
Float 8869.67M
% held by insiders 120.57%
% held by institutions 16.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 316 June 2016

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-478.66%

Management effectiveness

Return on assets (ttm)-45.80%
Return on equity (ttm)-90.98%

Income statement

Revenue (ttm)2.75M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-7.54M
EBITDA -13.17M
Net income avi to common (ttm)-13.17M
Diluted EPS (ttm)-0.0110
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.29M
Total cash per share (mrq)0.01
Total debt (mrq)122.41k
Total debt/equity (mrq)1.50
Current ratio (mrq)1.78
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-11.18M
Levered free cash flow (ttm)-9M